Autopsy report · NCT05412706

Niraparib Maintenance Treatment in mCRC With a Partial o Complete Response After Oxaliplatin-based Induction Therapy

“The Principal Investigator has retired and has not been replaced has retired and a new one has not been identified Principal Investigator”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Ospedale Policlinico San Martino

Sponsor type

University, hospital or other

Conditions

Metastatic Colorectal Cancer

Interventions

Niraparib

Participants

0

Trials that died the same way

• Target Sign vs Palpation for Radial Arterial Line Placement
  “Principal Investigator retired” (81% match in meaning)
• Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM
  “Principal Investigator has left the institution” (78% match in meaning)
• HCV Treatment With Fluvastatin, Simvastatin to Improve Interferon Sensitivity
  “Principal Investigator retiring” (78% match in meaning)
• Comparison of Two Macrolides, Azithromycin and Erythromycin, for Symptomatic Treatment of Gastroparesis
  “Original investigator left this institution, replacement investigator retired.” (75% match in meaning)
• Interest of Virtual Reality for the Management of Hospitalized Pregnant Patients at Risk of Preterm Delivery
  “departure of the principal investigator without replacement” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.